Arrowhead Pharmaceuticals, Inc.

ARWR

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0000879407

SEC filings (opens in a new tab)

In the last 90 days, Arrowhead Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 501 institutions reported holding it in 13F filings for Q2 2026, worth $9.73B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Arrowhead Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of ARWR: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Of which not filed for Q2 2024	Q2 2024	Change
Holders	273	1	272	0
Shares	96.7M	1.63M	97.7M	+2.63M (+2.8%)
Value	$2.76B	$46.5M	$2.54B	−$177.7M (−6.5%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (34)

Institutions that held Arrowhead Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to ARWR in Q2 2024
Institution	Shares	Value	% of portfolio
Squarepoint Ops LLC	383,826	$9.98M	0.04%
Hound Partners, LLC	269,929	$7.02M	1.41%
Standard Life Aberdeen plc	248,670	$6.46M	0.01%
Mirae Asset Global ETFs Holdings Ltd.	231,539	$6.02M	0.01%
Corebridge Financial, Inc.	220,371	$5.73M	0.03%
Superstring Capital Management LP	111,133	$2.89M	3.64%
Voloridge Investment Management, LLC	109,530	$2.85M	0.01%
Adage Capital Partners GP, L.L.C.	100,000	$2.60M	0.00%
Trexquant Investment LP	97,470	$2.53M	0.04%
Readystate Asset Management LP	56,492	$1.47M	0.07%
Edgestream Partners, L.P.	53,918	$1.40M	0.07%
CenterBook Partners LP	50,766	$1.32M	0.08%
Sphera Funds Management Ltd.	48,175	$1.25M	0.20%
Verition Fund Management LLC	42,351	$1.10M	0.01%
Fund 1 Investments, LLC	39,400	$1.02M	0.14%
Capital Fund Management S.A.	37,130	$965.0K	0.01%
Eisler Capital (US) LLC	32,054	$833.1K	0.16%
Brevan Howard Capital Management LP	24,489	$636.5K	0.04%
Toroso Investments, LLC	22,311	$579.9K	0.01%
Deerfield Management Company, L.P. (Series C)	19,461	$505.8K	0.01%
Fisher Asset Management, LLC	11,744	$305.2K	0.00%
Amundi	6,791	$170.3K	0.00%
Silicon Valley Capital Partners	6,477	$168.3K	0.02%
nVerses Capital, LLC	3,700	$96.2K	0.06%
Group One Trading, L.P.	586	$15.2K	0.00%
Picton Mahoney Asset Management	237	$6.00K	0.00%
Clearstead Advisors, LLC	144	$3.74K	0.00%
Itau Unibanco Holding S.A.	139	$3.61K	0.00%
Bessemer Group Inc	121	$3.00K	0.00%
Walleye Capital LLC	100	$2.60K	0.00%
Ronald Blue Trust, Inc.	44	$1.26K	0.00%
Huntington National Bank	12	$312	0.00%
Innealta Capital, LLC	11	$286	0.00%
MV Capital Management, Inc.	9	$234	0.00%

Sold out (34)

Institutions that held Arrowhead Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of ARWR in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
OrbiMed Advisors LLC	739,651	$21.2M
Octagon Capital Advisors LP	250,000	$7.15M
American International Group, Inc.	220,217	$6.30M
Natixis	204,000	$5.83M
Susquehanna Fundamental Investments, LLC	128,083	$3.66M
Texas Permanent School Fund	108,433	$3.10M
Tudor Investment Corp Et Al	69,330	$1.98M
Exome Asset Management LLC	55,700	$1.59M
Evolutionary Tree Capital Management, LLC	44,896	$1.28M
Campbell & CO Investment Adviser LLC	37,816	$1.08M
Harbor Capital Advisors, Inc.	26,832	$767.0K
Bayesian Capital Management, LP	25,303	$723.7K
Mariner, LLC	22,199	$634.9K
Panagora Asset Management Inc	18,542	$530.3K
Man Group plc	12,117	$346.5K
Gsa Capital Partners LLP	10,999	$315.0K
HSBC Holdings PLC	9,521	$272.3K
Oxford Asset Management LLP	9,520	$272.3K
Wolverine Trading, LLC	9,441	$270.0K
Pictet & Cie (Europe) SA	8,125	$232.4K
Graham Capital Management, L.P.	7,983	$228.3K
Mackenzie Financial Corp	7,299	$208.8K
Metropolitan Life Insurance Co	6,101	$174.5K
Headlands Technologies LLC	2,417	$69.1K
Fred Alger Management, LLC	1,543	$44.1K
Quest Partners LLC	970	$27.7K
Chilton Capital Management LLC	600	$17.2K
New Covenant Trust Company, N.A.	269	$7.69K
Global Assets Advisory, LLC	40,242	$1.43K
SYSTM Wealth Solutions LLC	42	$1.20K
Bell Investment Advisors, Inc	19	$544
Sofos Investments, Inc.	13	$402
Riggs Asset Managment Co. Inc.	14	$401
AdvisorNet Financial, Inc	7	$200

Not filed for Q2 2024 yet (1)

Institutions that held Arrowhead Pharmaceuticals, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ARWR in Q1 2024 that haven't filed for Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Credit Suisse AG	1,626,513	$46.5M